A New Stake in Evolv: Promise and Peril

Mittelman Wealth Management, in a quiet act of faith, added a substantial stake in Evolv Technologies, a company whose ambitions echo the distant hum of a distant future. The sum-$11.41 million-was not trivial, though it carried the weight of uncertainty, like a letter never opened, its contents unknown.

What happened

The fund, in its quarterly report, disclosed the purchase of 1,511,866 shares, a gesture both bold and hesitant. The value of this holding, 7.47% of the fund’s equity assets, suggested a calculated risk, yet the numbers themselves were a riddle: a company with a market cap of nearly a billion, yet net income in the red, its revenues a flickering flame.

The fund’s portfolio, a mosaic of cautious bets, now bore the weight of this new acquisition. It was as if, in the quiet hours of the market’s calendar, a single note had been struck, resonating with the faintest hope.

What else to know

The fund’s top holdings, a tapestry of ETFs, now included this singular, untested venture. The Vanguard funds, steady and familiar, stood beside Evolv, a curious juxtaposition. One might wonder if the fund’s managers, in their deliberations, felt the same unease as a traveler pausing at the edge of an uncharted forest.

As of Nov. 20, 2025, the stock’s price had surged, yet the question lingered: was this a triumph, or merely a fleeting gust of wind?

Company Overview

Metric	Value
Price (as of market close 2025-11-20)	$5.66
Market capitalization	$987.46 million
Revenue (TTM)	$136.50 million
Net income (TTM)	$-59.74 million

Company Snapshot

Evolv Technologies, with its promises of safety and innovation, offers systems that detect threats with the grace of a well-practiced ritual. Yet, the market remains skeptical, its gaze lingering on the numbers, the red ink, the unfulfilled potential.

The company’s solutions, though lauded, are still a work in progress, their efficacy measured not in certainty, but in the quiet hope of those who walk through their gates.

Foolish take

The fund’s decision, though curious, was not without precedent. In the world of finance, even the most cautious investors are drawn to the allure of growth, however fragile. Evolv’s story, one of ambition and resilience, is not unlike the tales of small towns striving to build a future against the odds.

Its revenue, growing steadily, is a testament to the tenacity of its vision. Yet, the path ahead is fraught with uncertainty, a journey where every step is both a triumph and a question.

And so, the market turns, as it always does, with the same quiet persistence, leaving questions unanswered and dreams unfulfilled.

Glossary

Position: A quiet commitment, a thread in the tapestry of a portfolio.
Assets Under Management (AUM): The sum of all hopes and fears, measured in dollars.
Form 13-F: A document of transparency, yet one that speaks in riddles.
Reportable assets: The visible fragments of a larger, unseen whole.
Allocation: A choice made in the dim light of uncertainty.
Stake: A wager on a future that may never arrive.
Outperforming: A fleeting victory, soon overshadowed by new challenges.
Touchless security screening: A promise of safety, yet one that must be earned.
Subscription (in context): A recurring hope, a payment for the unknown.
TTM: A measure of time, yet one that cannot predict the future.

And so, the story continues, as it always does, with the same quiet persistence, leaving questions unanswered and dreams unfulfilled. 🕊️

2025-11-21 07:22